UniProt ID | TIGAR_HUMAN | |
---|---|---|
UniProt AC | Q9NQ88 | |
Protein Name | Fructose-2,6-bisphosphatase TIGAR {ECO:0000305} | |
Gene Name | TIGAR {ECO:0000303|PubMed:16839880} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 270 | |
Subcellular Localization | Cytoplasm . Nucleus . Mitochondrion . Translocated to the mitochondria during hypoxia in a HIF1A-dependent manner (PubMed:23185017). Colocalizes with HK2 in the mitochondria during hypoxia (PubMed:23185017). Translocated to the nucleus during hypoxia | |
Protein Description | Fructose-bisphosphatase hydrolyzing fructose-2,6-bisphosphate as well as fructose-1,6-bisphosphate. [PubMed: 19015259 Acts as a negative regulator of glycolysis by lowering intracellular levels of fructose-2,6-bisphosphate in a p53/TP53-dependent manner, resulting in the pentose phosphate pathway (PPP) activation and NADPH production] | |
Protein Sequence | MARFALTVVRHGETRFNKEKIIQGQGVDEPLSETGFKQAAAAGIFLNNVKFTHAFSSDLMRTKQTMHGILERSKFCKDMTVKYDSRLRERKYGVVEGKALSELRAMAKAAREECPVFTPPGGETLDQVKMRGIDFFEFLCQLILKEADQKEQFSQGSPSNCLETSLAEIFPLGKNHSSKVNSDSGIPGLAASVLVVSHGAYMRSLFDYFLTDLKCSLPATLSRSELMSVTPNTGMSLFIINFEEGREVKPTVQCICMNLQDHLNGLTETR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Ubiquitination | HGETRFNKEKIIQGQ CCCCCCCHHHHHCCC | 58.64 | 22817900 | |
20 | Acetylation | ETRFNKEKIIQGQGV CCCCCHHHHHCCCCC | 46.87 | 23236377 | |
20 | Malonylation | ETRFNKEKIIQGQGV CCCCCHHHHHCCCCC | 46.87 | 26320211 | |
20 | Ubiquitination | ETRFNKEKIIQGQGV CCCCCHHHHHCCCCC | 46.87 | 21906983 | |
34 | Phosphorylation | VDEPLSETGFKQAAA CCCCCCHHCHHHHHH | 44.54 | 22817900 | |
37 | Ubiquitination | PLSETGFKQAAAAGI CCCHHCHHHHHHHCH | 40.13 | 21906983 | |
37 | Methylation | PLSETGFKQAAAAGI CCCHHCHHHHHHHCH | 40.13 | 42373057 | |
50 | Acetylation | GIFLNNVKFTHAFSS CHHHCCCCCCCCCCH | 46.82 | 19608861 | |
61 | Methylation | AFSSDLMRTKQTMHG CCCHHHHHCHHHHHH | 46.17 | 115918477 | |
63 | Ubiquitination | SSDLMRTKQTMHGIL CHHHHHCHHHHHHHH | 33.15 | 29967540 | |
80 | Phosphorylation | SKFCKDMTVKYDSRL HHHHCCCCCEECHHH | 24.79 | - | |
82 | Acetylation | FCKDMTVKYDSRLRE HHCCCCCEECHHHHH | 33.89 | 26051181 | |
83 | Phosphorylation | CKDMTVKYDSRLRER HCCCCCEECHHHHHH | 18.15 | - | |
85 | Phosphorylation | DMTVKYDSRLRERKY CCCCEECHHHHHHHC | 30.08 | - | |
91 | Ubiquitination | DSRLRERKYGVVEGK CHHHHHHHCCEECCH | 41.42 | 29967540 | |
92 | Phosphorylation | SRLRERKYGVVEGKA HHHHHHHCCEECCHH | 22.75 | 29496907 | |
98 | Ubiquitination | KYGVVEGKALSELRA HCCEECCHHHHHHHH | 32.42 | 24816145 | |
101 | Phosphorylation | VVEGKALSELRAMAK EECCHHHHHHHHHHH | 39.17 | - | |
129 | 2-Hydroxyisobutyrylation | GETLDQVKMRGIDFF CCCHHHHHHCCCCHH | 19.76 | - | |
129 | Ubiquitination | GETLDQVKMRGIDFF CCCHHHHHHCCCCHH | 19.76 | 24816145 | |
150 | Ubiquitination | ILKEADQKEQFSQGS HHHHHHHHHHHHCCC | 54.77 | 29967540 | |
154 | Phosphorylation | ADQKEQFSQGSPSNC HHHHHHHHCCCCCHH | 33.07 | 17525332 | |
157 | Phosphorylation | KEQFSQGSPSNCLET HHHHHCCCCCHHHHH | 19.95 | 21712546 | |
159 | Phosphorylation | QFSQGSPSNCLETSL HHHCCCCCHHHHHHH | 41.70 | 28464451 | |
164 | Phosphorylation | SPSNCLETSLAEIFP CCCHHHHHHHHHHCC | 18.98 | 22199227 | |
165 | Phosphorylation | PSNCLETSLAEIFPL CCHHHHHHHHHHCCC | 19.06 | 22199227 | |
174 | Ubiquitination | AEIFPLGKNHSSKVN HHHCCCCCCCCCCCC | 60.20 | 29967540 | |
182 | Phosphorylation | NHSSKVNSDSGIPGL CCCCCCCCCCCCCCH | 35.82 | 20068231 | |
184 | Phosphorylation | SSKVNSDSGIPGLAA CCCCCCCCCCCCHHH | 38.14 | 20068231 | |
192 | Phosphorylation | GIPGLAASVLVVSHG CCCCHHHHHEHHCCC | 15.46 | 20068231 | |
197 | Phosphorylation | AASVLVVSHGAYMRS HHHHEHHCCCHHHHH | 14.55 | 20068231 | |
201 | Phosphorylation | LVVSHGAYMRSLFDY EHHCCCHHHHHHHHH | 9.54 | 20068231 | |
204 | Phosphorylation | SHGAYMRSLFDYFLT CCCHHHHHHHHHHHH | 19.50 | 21712546 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TIGAR_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TIGAR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TIGAR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
UB2L3_HUMAN | UBE2L3 | physical | 22939629 | |
TSC2_HUMAN | TSC2 | physical | 22939629 | |
RL11_HUMAN | RPL11 | physical | 21988832 | |
PCBP1_HUMAN | PCBP1 | physical | 26344197 | |
TKT_HUMAN | TKT | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34, AND MASSSPECTROMETRY. |